Advances in the understanding of lung cancer

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2519-2522

  Groeger, A M ^a,e   Esposito, V ^b,c   Mueller, M R ^a   Caputi, M ^b   Kaiser, H E ^d   Giordano, A ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

Lung neoplasms; Occupational carcinogens; Race; Sex; Tumor markers

Indexed keywords

ANTINEOPLASTIC AGENT; TOBACCO SMOKE;

CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; HUMAN; LUNG CANCER; MEDICAL RESEARCH; MOLECULAR BIOLOGY; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; TUMOR SUPPRESSOR GENE;

CHROMOSOME MAPPING; GENE AMPLIFICATION; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; ONCOGENES; TUMOR CELLS, CULTURED;

EID: 0030755646     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Shimizu H: Recent trends in lung cancer epidemiology. Nippon Kyobu Shikkan Gakkai Zasshi: 32 Suppl: 183-186, 1994.
2. Lebeau B: Broncho-pulmonary cancer: what s new? Ann Pathol 13(6): 368-371, 1993.
3. Perera FP: Molecular epidemiology and prevention of cancer. Environ Health Perspect 103 (8): 233-36, 1995.
4. Van Loon AJ, Burg J, Goldbohm RA, Van Den Brandt PA: Differences in cancer incidence and mortality among socio-economic groups. Scand J Soc Med 23(2): 110-120, 1995.
5. Kleinjans JC, Van Maanen JM, Van Schooten FJ: Human respiratory disease: environmental and lung cancer risk. Ciba Found Symp 175-178, 1993.
6. Cagle PT: Molecular pathology of lung cancer and its clinical relevance. Monogr Pathol 36: 134-144, 1993.
7. Nikoinski J, Furman M: Clinical tumor markers in lung cancer. Eur J Cancer Prev4 (2): 129-138, 1995
8. Auerbach O, Stout AP, Hammond EC et al: Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 265: 235, 1961.
9. Auerbach O, Gere JB, Forman JB et al: Changes in bronchial epithelium in relation to smoking and cancer of the lung: A report of progress. N Engl J Med 256: 97, 1957.
10. Gosney JR, Sissons MCJ, Allibone RO: Neuroendocrine cell populations in normal human lungs: A quantitative study. Thorax 43: 878, 1988.
11. Gould VE, Linnoila RI, Memoli VA et al: Neuroendocrine components of bronchopulmonary tract: Hyperplasia, dysplasia, and neoplasms. Lab Invest 49: 519, 1983
12. Levin WJ, Press MF, Gaynor Rb, Sukhatme VP, Boone TC, Reissman PT, Figlin RA, Holmes EC, Souza LM, Slamon DJ: Expression patterns of immediate early transcription factors in human non small cell lung cancer. The lung cancer study group. Oncogene 11 (7): 1261-1269, 1995.
13. Little CD, Nau MM, Carney DN et al: Amplification and expression of the cmyc oncogene in human lung cancer cell lines. Nature 306: 194, 1983.
14. Gazdar F, Carney DN, Nau MM et al: Characterization of variant subclasses of small cell lung cancer cell lines having classic and variant features. Cancer Res 45: 29-24, 1985.
15. Carney DN, Mitchel JB, Kinsella TJ: In vitro radiation and chemosensitivity of established human small cell lung cancer and its large cell morphology variants. Cancer Res 43: 2806, 1983.
16. Brennan J, O Connor T, Makuch RW et al: Myc family DNA amplification in 107 tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regiments. Cancer Res 51: 1708.
17. Johnson BE, Makuch RW, Simmons AD et al: Myc family DNA amplification in small cell lung cancer patients tumors and corresponding cell lines. Cancer Res 48: 51-63, 1988.
18. Noguchi M, Hirohashi S, Hara F et al: Heterogenous amplification of myc family oncogenes in small cell lung carcinoma. Cancer 66: 20-53, 1990.
19. Takahashi T, Obata Y, Sekido Y et al: Expression and ampilification of myc gene family in small cell lung cancer cell lines. Cancer Res 47: 6236, 1987.
20. Wong AJ, Ruppert JM, Eggleston J et al: Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 233: 461, 1986.
21. Gemma A, Nakajima T, Shiraishi M et al: Myc family gene abnormality in lung cancers and its relation to xenotransplantability. Cancer Res 48: 6025, 1988.
22. Shiraishi M, Noguchi M, Shimosato Y et al: Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 49: 6474, 1989.
23. Barbacid M: Ras genes. Annu Rev Biochem 56:779, 1987.
24. Slebos RJC, Rodenhuis S: The ras family in human non-small cell lung cancer. J Natl Cancer Inst Monogr 13: 23, 1992.
25. Suzuki Y, Orita M, Shiraishi M et al: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5: 1037, 1990.
26. Yakuboskaya MS, Spiegelman V, Luo FC, Malaev S, Salnev A, Zboroskaya I, Gasparyan A, Polotsky B, Machaöadze Z, Trachtenberg AC: High frequence of K-ras mutation in normal appearing lung tissues and sputum of patients with lung cancer. Int J Cancer 4 (%): 543-48, 1995.
27. Nelson MA, Wymer J, Clements N jr: Detection of k-ras gene mutations in non neoplastic lung tissue and lung cancers. Cancer Lett 103(1): 115-21, 1996.
28. Mitsudomi T, Viallet J, Mulshine JL et al: Mutations of ras genes distinguish a subset of non-small cell lung cancer cell lines from smallcell cancer lines. Oncogene 6: 1353, 1991.
29. Rodenhuis S, Van de Wetering ML, Mooi WJ et al: Mutational activation of K-ras oncogene: a possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 377: 929, 1987.
30. Rodenhuis S, Slebos RJC, Boot AJM et al: Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the lung. Cancer Res 48: 5738, 1988.
31. Lung ML, Wong M, Lam WK et al: Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer 70: 760, 1992.
32. Slebos RJC, Hruban RH, Dalesio O et al: Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst 83: 1024, 1991.
33. Sugio K, Ishida T, Yokoyama H et al: Ras gene mutations as a prognostic marker in adenocarcinoma of human lung without lymph node metastases. Cancer Res 52: 2903, 1992.
34. Husgafvel-Pursiainen K, Hackman P, Ridanpaa M et al: Assiciation with smoking and occupational exposure to asbestos. Int J Cancer 53: 250, 1993.
35. Mitsudomi T, Steinberg SM, Oie HK et al: Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res 57: 4999, 1991.
36. Sundaresan V, Ganly P, Hasleton P et al: P53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989, 1992.
37. Yokota J, Wada M, Shimosato Y et al: Loss of heterozygosity of chromosomes 3, 13, 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 84: 9252, 1987.
38. Kok K, Osinga J, Carritt B et al: Deletion of DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 330: 578, 1987.
39. Brauch H, Johnson BE, Hovis J et al: Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N Engl J Med 377: 1109, 1987.
40. Leduc F, Brauch H, Haij C et al: Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers. Am J Hum Genet 44: 282, 1989.
41. Brauch H, Tory K, Kotler F et al: Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes Chromosom Cancer 1: 240, 1990.
42. Weston A, Willey JC, Modali R et al: Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, largecell carcinoma and adenocarcinoma of human lung. Proc Natl Acad Sci USA 86: 5009, 1989.
43. Rabbitts P, Douglas J, Daly M et al: Frequency and extent of allelic loss in the short arm of chromosome 3 in non-small-cell lung cancer. Genes Chromosom Cancer 1: 95, 1989.
44. Wang X, Christiani DC, Wiencke JK, Fishbein M, Xu X, Cheng TJ, Mark E, Wain JC, Kelsey KT: Mutation in the gene in lung cance are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol Biomarkers Prev 4 (5): 543-548, 1995.
45. Suzuki H, Takahashi T, Kuroishi T et al: P53 mutations in non-small-cell lung cancer in Japan: Association between mutations and smoking. Cancer Res 52: 734, 1992.
46. Mitsudomi T, Qyama T, Kusano T et al: Mutations of p53 gene as a predictor of poor prognosis in patients with non-smal-cell lung cancer. J Natl Cancer Inst 85: 2018, 1993.
47. Esposito V, De Luca A, Baldi A, D'Aponte A, Cavallotti I, Meoli I, Baldi F, Caputi M, Giordano A: Altered expression of p53 and Rb tumor suppressor genes in lung cancer: relationship with survival. Int J Oncol 9: 439-443, 1996.
48. Lee WH, Bookstein R, Hong F et al: Human retinoblastoma susceptibility gene: Cloning, identification and sequence. Science 235: 1394, 1987.
49. Baldi, A, Boccia, V, Claudio PP, De Luca A, Giordano A: Genomic structure of the human retinoblastoma-related Rb2/pl30 gene. Proc Natl Acad Sci USA 93: 4629-4632, 1996.
50. Mayol X, Grana X, Baldi A, Sang N, Hu Q,Giordano A: Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1 A transforming domain. Oncogene 8: 2561-2566, 1993.
51. Ewen ME, Xing Y, Lawrence JB, Livingston DM: Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66: 1155-1164, 1991.
52. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Su Y, Colburn N, Calabretta B, Giordano A: pRb2/p130 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54: 5556-5560, 1994.
53. Claudio PP, De Luca A, Howard CM, Baldi A, Firpo JM, Koff A, Paggi MG, Giordano A: Functional interaction of Rb2/pl30 with cyclins. Cancer Res 56: 2003-2008, 1996.
54. Baldi A, Esposito V, De Luca A, Howard CM, Mazzarella G, Baldi F, Caputi M, Giordano A: Differential expression of the retinoblastoma gene family members, pRb/p105, p107, and pRb2/p130 in lung cancer. Clinical Cancer Res 2:1239-1245, 1996.
55. Giordano A, Kaiser HE: The Retinoblastoma gene: its role in the cell cycle and cancer. In Vivo 10: 223-228, 1996.
56. Paggi MG, Baldi A, Bonetto F, Giordano A: The retinoblastoma protein family in cell cycle and cancer. A Review. J Cell Biochem 62: 418-430, 1996.